Multiple cyclophilins involved in different cellular pathways mediate HCV replication
about
Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretionThe transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3Chaperones in hepatitis C virus infectionHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionSuppression of coronavirus replication by cyclophilin inhibitorsCuring a viral infection by targeting the host: the example of cyclophilin inhibitorsCyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5AThe Roles of Syncytin-Like Proteins in Ruminant PlacentationConformational Heterogeneity of Cyclosporin A in Cyclophilin 18 BindingCharacterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approachMolecular cloning, expression, and characterization of cyclophilin A from Clonorchis sinensis.Systematic identification of novel, essential host genes affecting bromovirus RNA replication.Potential treatment options and future research to increase hepatitis C virus treatment response rateDomain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A.New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization.The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.CYP1, a hypovirus-regulated cyclophilin, is required for virulence in the chestnut blight fungus.Cyclosporin A inhibits the replication of diverse coronavirusesCurrent approaches on viral infection: proteomics and functional validations.Anti-HCV drugs in the pipeline.Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infectionTombusvirus-yeast interactions identify conserved cell-intrinsic viral restriction factors.The role of immunophilins in viral infection.Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands.Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis.Multiple mutations in hepatitis C virus NS5A domain II are required to confer a significant level of resistance to alisporivirSuppression of feline coronavirus replication in vitro by cyclosporin A.Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family.Identification of low abundance cyclophilins in human plasma.Activation of the Mitochondrial Apoptotic Signaling Platform during Rubella Virus Infection.Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme.The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.Update on alisporivir in treatment of viral hepatitis C.The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction.Chemotactic activity of channel catfish, Ictalurus punctatus (Rafinesque), recombinant cyclophilin A.
P2860
Q24308039-80FD8688-2D43-45DA-8213-3E5A1FA2E423Q24336528-5E0AA691-F873-4DEF-BAB8-B941A7C13951Q26771251-0BDCDB7F-9D25-42B5-976E-396E293A994DQ26779128-6CAE8BFE-443A-4AFF-8799-78E5F023912EQ26825245-73F24834-C6D0-40A8-96B7-7C1D4B2D8CD1Q26828727-177B302B-EC7D-455A-9FAF-898EEF42E878Q27491303-32968730-319F-49DC-AB5B-25D231CFBFA7Q28086836-835C0030-EBA7-489F-A363-6E273C5FB121Q28551403-B32B22BF-3448-48CB-9B92-8347DC50BA72Q28551538-DB6D552D-288E-4D41-BB3F-C30FD63FD899Q33707739-D704838A-9AF8-4D14-928E-A1D939A5C64FQ33832435-9E56BF1E-9230-4B40-AB3E-7CD58FC7D0A4Q34018821-CC98439D-884E-4056-BE7C-04C88C804295Q34576190-1903D568-0B81-4378-B1E5-23E46E99BF22Q35063336-24401121-AA48-4441-935D-D7035F42DDBFQ35653358-668C7C64-E3D0-433F-A2D1-0AD263A2F9F7Q35656614-971C93AD-5883-4BAE-94E4-7640F7F74F10Q35742761-83C60E58-0CFF-4B45-982C-68DF983DBBE7Q35855258-3D44C8C9-0EF1-4CBA-8950-765DF0280D70Q35960586-9A391B06-D78E-4E32-B478-F504845A3474Q36404090-5AEAB388-4F6D-4A1A-AC0C-A484523764F4Q37177740-DD0F9B9B-04D5-4192-B037-4D8CFB250311Q37968485-65DFAD13-7538-4A9D-BC15-D013C9482D5FQ38064282-DBD80CB3-0E1F-47DE-BF33-0161D5EAA6B4Q38243326-1D048253-C86F-4C3B-9BB3-B08EFE48A34EQ38274889-F38021B2-F461-440D-933D-4B487F69A111Q39018864-B7B8BA22-429C-4DE9-89ED-ADEEFAF222ADQ39155902-DFD33F58-E82D-4E04-A6D8-F4FFB29B12BEQ39244702-9E307386-7F1A-432A-9944-E99D1B23011EQ39313413-A3E19ADD-ED63-4897-ADA2-BF2889BBD197Q39356376-6874D2D1-54C4-4132-823A-8D6E90B48B1BQ39579921-C76E7246-72BD-43B4-8FC8-9B8F7C75FC89Q40469235-A1D48646-9024-4B5D-B1FE-E758809B308DQ40857658-9258AAC5-5405-48E3-A85C-EF424B7EC99AQ41082755-0B487FF3-D9DA-4B4E-9A77-1932C322E059Q41843629-C4D09B4B-9AF4-432D-8DD1-8D7EB0E3BEE6Q42977561-244C0784-4B3D-4BE0-B87B-307ABD954E79Q43047940-022EA009-7625-4C98-AF39-646574442139Q51027272-791B366C-CCB2-4C59-B4C7-95278394A534
P2860
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@ast
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en-gb
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@nl
type
label
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@ast
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en-gb
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@nl
prefLabel
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@ast
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en-gb
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@nl
P2093
P921
P3181
P1433
P1476
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
@en
P2093
Brigitte Wiedmann
Chad Vickers
Christina Rau
Craig Mickanin
Gejing Deng
Gerard Joberty
Jason Borawski
Jeremy Baryza
Kara A Balabanis
P3181
P356
10.1016/J.VIROL.2009.10.043
P407
P577
2010-02-05T00:00:00Z